Fundraising Fox
/Companies
Sign in

Panome Bio

Saint Louis, US · Founded 2022 · Delaware corporation · 26 employees on LinkedIn · 3 known investors

Find your way into Panome Bio

Sign up to see every warm intro you have to Panome Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Panome Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.

AI & Machine LearningBiotechDeep TechHealthtech

Founders & leadership

Panome Bio was founded in 2022 by Edward Weinstein and Tom Cohen.

EWEdward Weinstein
Edward WeinsteinCo-Founder and CEOEdward Weinstein has over 20 years of leadership experience in the life sciences sector, including roles in genetic engineering and personalized medicine, and currently leads Panome Bio as Executive Officer and Director.
TCTom Cohen
Tom CohenCo-Founder and President

Board

DSDavid Smoller
David SmollerCo-Founder/Board MemberGeneral Partner at Cultivation Capital
DLDeval Lashkari
Deval LashkariDirector Board of DirectorsSenior Partner at Telegraph Hill Partners
AHAlexander Herzick
Alexander HerzickBoard directorPartner at Telegraph Hill Partners
RCRob Capone
Rob CaponeBoard directorPartner at Telegraph Hill Partners

Investors · 3

Telegraph Hill Partnerslisted by Telegraph Hill PartnersSan Francisco · $2M – $8M

How we know: Telegraph Hill Partners's portfolio page · a partner's Signal profile · funding news · prnewswire.com · Not right? Tell us

Cultivation CapitalinferredSt. Louis · $100K – $3.5Mvia David Smoller · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$12M disclosed across 2 rounds · 2023–2024

▶$6MraisedNov 2024 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SmollerDirector
  • Tom CohenExecutive Officer
  • Rob CaponeDirector
  • Edward WeinsteinExecutive Officer, Director
  • Deval LashkariDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$25K
First sale
Nov 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedFeb 2023 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SmollerDirector
  • Deval LashkariDirector
  • Alexander HerzickDirector
  • Edward WeinsteinExecutive Officer, Director
  • Tom CohenExecutive Officer
  • Rob CaponeDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$20K
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Panome Bio went on to found or lead other companies.

David SmollerDirectorFounded Solis AgrosciencesEdward WeinsteinExecutive Officer, DirectorFounded Canopy Biosciences

Related companies · 2

OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Metabolon, Inc.Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data. It serves biopharma, public health, consumer wellness, agriculture, and academic research clients across discovery, clinical, and translational studies.

Companies working in the same space as Panome Bio.

In the news

Panome Bio Raises Growth Capital From Telegraph Hill Partners To Expand Next-Generation Metabolomics & Proteomics Businessprnewswire.com · Mar 2023Panome Bio Raises Growth Fundingfinsmes.com · Mar 2023

Frequently asked questions

What does Panome Bio do?
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.
Who founded Panome Bio?
Panome Bio was founded by Edward Weinstein, Tom Cohen in 2022.
Who are Panome Bio's investors?
Panome Bio's investors include BioGenerator Ventures, Telegraph Hill Partners, Cultivation Capital.
How much funding has Panome Bio raised?
Panome Bio has disclosed $12M raised across 2 rounds.
Where is Panome Bio headquartered?
Panome Bio is headquartered in Saint Louis, US.